Stock Taper
Latest 13F filing data - Q3 2024
| STOCK | TICKER | SHARES HELD▲ ▼ | VALUE▲ ▼ |
|---|---|---|---|
Larimar Therapeutics, Inc. | LRMR | 200K | $1.31M |
Edgewise Therapeutics, Inc. | EWTX | 195K | $5.2M |
Janux Therapeutics, Inc. | JANX | 190K | $8.63M |
BridgeBio Pharma, Inc. | BBIO | 175K | $4.46M |
enGene Holdings Inc. | ENGN | 160.9K | $1.06M |
| CP CRINETICS PHARMACEUTICALS IN | CRNX | 150K | $7.67M |
Arvinas, Inc. | ARVN | 145K | $3.57M |
Viking Therapeutics, Inc. | VKTX | 140K | $8.86M |
Axsome Therapeutics, Inc. | AXSM | 135K | $12.13M |
MoonLake Immunotherapeutics | MLTX | 128.41K | $6.47M |
Capricor Therapeutics, Inc. | CAPR | 125K | $1.9M |
Sarepta Therapeutics, Inc. | SRPT | 120K | $14.99M |
Korro Bio, Inc. | KRRO | 110K | $3.68M |
Novo Nordisk A/S | NVO | 110K | $13.1M |
Dyne Therapeutics, Inc. | DYN | 100K | $3.59M |
Summit Therapeutics Inc. | SMMT | 85K | $1.86M |
Vaxcyte, Inc. | PCVX | 80K | $9.14M |
Rhythm Pharmaceuticals, Inc. | RYTM | 78.84K | $4.13M |
Viridian Therapeutics, Inc. | VRDN | 75K | $1.71M |
Insmed Incorporated | INSM | 75K | $5.47M |